Skip to main content
. 2023 Feb 23;2023(2):CD015171. doi: 10.1002/14651858.CD015171.pub2

3.3. Analysis.

3.3

Comparison 3: Antiviral versus placebo/no treatment, Outcome 3: Disease‐specific health‐related quality of life at 3 to < 6 months